FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034324871> ?p ?o ?g. }

• W3034324871 abstract "We tested whether circulating metabolites reflecting cytosolic (lactate/pyruvate) or mitochondrial (β-hydroxybutyrate/acetoacetate [AcAc]) redox balance are associated with major clinical outcomes in patients with type 2 diabetes. The CANVAS study randomized participants to placebo (Plb) or canagliflozin (100mg or 300mg) (Tx) and followed them for up to 6 years. Metabolic markers were measured at baseline (2,373 in Tx [dose combined] and 1,185 in Plb), at year 1 (2,022 in Tx and 949 in Plb) and year 2 (1,793 in Tx and 834 in Plb). By linear mixed model analysis, plasma free fatty acids, AcAc, and β-hydroxybutyrate increased with Tx vs. Plb, whereas plasma pyruvate decreased with Tx while glycerol and lactate did not change significantly. Of note, these changes were independent of the background antihyperglycemic medication (metformin, sulfonylureas, insulin, or combinations thereof). The incidence of hospitalized heart failure or cardiovascular death (HHF/CVD) was 10.2%, the incidence of the renal composite endpoint (CombR; i.e., 40% reduction in eGFR or renal replacement/death) was 3.9%. In Cox models adjusting for sex, age, BMI, HbA1c, baseline systolic blood pressure, diabetes duration, smoking, baseline use of diuretics or statins, history of heart failure, prior CV disease, and Tx, baseline AcAc was a negative predictor of HHF/CVD (HR=0.83 [95%CI 0.75-0.94]), while baseline lactate was a positive predictor (HR=1.42 [95%CI 1.20-1.68]). Adding baseline ACR and eGFR to the same multivariate model for CombR as the outcome, AcAc was still a negative (HR=0.84 [95%CI 0.75-0.94]) and lactate still a positive predictor (HR=1.42 [95%CI 1.20-1.67]). For CV and renal outcomes, higher baseline plasma lactate is an independent positive risk marker potentially reflecting a reducing cytosolic redox shift, but higher baseline plasma AcAc is a protective factor, which may be related to efficient mitochondrial supply/usage of reducing equivalents. Further analysis is needed to test these hypotheses. Disclosure E. Ferrannini: Consultant; Self; Boehringer Ingelheim International GmbH, Eli Lilly and Company, Oramed Pharmaceuticals. Research Support; Self; AstraZeneca, Janssen Pharmaceuticals, Inc. S. Baldi: None. T. Scozzaro: None. F. Tesfaye: Employee; Self; Janssen Research & Development, LLC. W. Shaw: Employee; Self; Janssen Pharmaceuticals, Inc. N. Rosenthal: None. K.W. Mahaffey: Consultant; Self; Medscape, Mitsubishi, Myokardia, NIH, Novartis, Novo Nordisk, Portola, Radiometer, Regeneron, SmartMedics, Springer Publishing, UCSF. Research Support; Self; Afferent, Amgen, Apple, Inc, AstraZeneca, Cardiva Medical, Inc, Daiichi, Ferring, Google (Verily), Johnson & Johnson, Luitpold, Medtronic, Merck, NIH, Novartis, Sanofi, St. Jude, Tenax. B. Neal: Research Support; Self; Janssen Research & Development, LLC, Merck Schering Plough, Roche Pharma, Servier, Zydus Pharmaceuticals, Inc. Other Relationship; Self; Abbott, Janssen, Novartis, Pfizer, Roche, and Servier. V. Perkovic: Other Relationship; Self; See Other Relationship field. M.K. Hansen: Employee; Self; Janssen Research & Development, LLC. Funding Janssen Research & Development, LLC" @default.
• W3034324871 created "2020-06-19" @default.
• W3034324871 creator A5004194306 @default.
• W3034324871 creator A5018696269 @default.
• W3034324871 creator A5027520502 @default.
• W3034324871 creator A5031260299 @default.
• W3034324871 creator A5039432822 @default.
• W3034324871 creator A5053710319 @default.
• W3034324871 creator A5066887782 @default.
• W3034324871 creator A5075162144 @default.
• W3034324871 creator A5089294363 @default.
• W3034324871 creator A5089847244 @default.
• W3034324871 date "2020-06-01" @default.
• W3034324871 modified "2023-10-17" @default.
• W3034324871 title "139-LB: The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS" @default.
• W3034324871 doi "https://doi.org/10.2337/db20-139-lb" @default.
• W3034324871 hasPublicationYear "2020" @default.
• W3034324871 type Work @default.
• W3034324871 sameAs 3034324871 @default.
• W3034324871 citedByCount "0" @default.
• W3034324871 crossrefType "journal-article" @default.
• W3034324871 hasAuthorship W3034324871A5004194306 @default.
• W3034324871 hasAuthorship W3034324871A5018696269 @default.
• W3034324871 hasAuthorship W3034324871A5027520502 @default.
• W3034324871 hasAuthorship W3034324871A5031260299 @default.
• W3034324871 hasAuthorship W3034324871A5039432822 @default.
• W3034324871 hasAuthorship W3034324871A5053710319 @default.
• W3034324871 hasAuthorship W3034324871A5066887782 @default.
• W3034324871 hasAuthorship W3034324871A5075162144 @default.
• W3034324871 hasAuthorship W3034324871A5089294363 @default.
• W3034324871 hasAuthorship W3034324871A5089847244 @default.
• W3034324871 hasConcept C126322002 @default.
• W3034324871 hasConcept C134018914 @default.
• W3034324871 hasConcept C142724271 @default.
• W3034324871 hasConcept C164705383 @default.
• W3034324871 hasConcept C204787440 @default.
• W3034324871 hasConcept C207103383 @default.
• W3034324871 hasConcept C27081682 @default.
• W3034324871 hasConcept C2777180221 @default.
• W3034324871 hasConcept C2777451236 @default.
• W3034324871 hasConcept C2778198053 @default.
• W3034324871 hasConcept C2779306644 @default.
• W3034324871 hasConcept C2780323712 @default.
• W3034324871 hasConcept C44249647 @default.
• W3034324871 hasConcept C50382708 @default.
• W3034324871 hasConcept C555293320 @default.
• W3034324871 hasConcept C71924100 @default.
• W3034324871 hasConcept C84393581 @default.
• W3034324871 hasConcept C90924648 @default.
• W3034324871 hasConceptScore W3034324871C126322002 @default.
• W3034324871 hasConceptScore W3034324871C134018914 @default.
• W3034324871 hasConceptScore W3034324871C142724271 @default.
• W3034324871 hasConceptScore W3034324871C164705383 @default.
• W3034324871 hasConceptScore W3034324871C204787440 @default.
• W3034324871 hasConceptScore W3034324871C207103383 @default.
• W3034324871 hasConceptScore W3034324871C27081682 @default.
• W3034324871 hasConceptScore W3034324871C2777180221 @default.
• W3034324871 hasConceptScore W3034324871C2777451236 @default.
• W3034324871 hasConceptScore W3034324871C2778198053 @default.
• W3034324871 hasConceptScore W3034324871C2779306644 @default.
• W3034324871 hasConceptScore W3034324871C2780323712 @default.
• W3034324871 hasConceptScore W3034324871C44249647 @default.
• W3034324871 hasConceptScore W3034324871C50382708 @default.
• W3034324871 hasConceptScore W3034324871C555293320 @default.
• W3034324871 hasConceptScore W3034324871C71924100 @default.
• W3034324871 hasConceptScore W3034324871C84393581 @default.
• W3034324871 hasConceptScore W3034324871C90924648 @default.
• W3034324871 hasIssue "Supplement_1" @default.
• W3034324871 hasLocation W30343248711 @default.
• W3034324871 hasOpenAccess W3034324871 @default.
• W3034324871 hasPrimaryLocation W30343248711 @default.
• W3034324871 hasRelatedWork W2005084305 @default.
• W3034324871 hasRelatedWork W2016264464 @default.
• W3034324871 hasRelatedWork W2033313326 @default.
• W3034324871 hasRelatedWork W2168926920 @default.
• W3034324871 hasRelatedWork W2281604365 @default.
• W3034324871 hasRelatedWork W2301851732 @default.
• W3034324871 hasRelatedWork W2319523397 @default.
• W3034324871 hasRelatedWork W2744240433 @default.
• W3034324871 hasRelatedWork W2778201550 @default.
• W3034324871 hasRelatedWork W2035069710 @default.
• W3034324871 hasVolume "69" @default.
• W3034324871 isParatext "false" @default.
• W3034324871 isRetracted "false" @default.
• W3034324871 magId "3034324871" @default.
• W3034324871 workType "article" @default.